Patients' knowledge of pregnancy‐related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’)
- 9 May 2012
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 36 (1) , 57-63
Abstract
Summary: Background: Inflammatory bowel diseases (IBD) require complex therapeutic decisions and life choices concerning pregnancy, but little is known about patient's knowledge of IBD and its treatment before and during pregnancy.Aim: To develop a novel tool (Crohn's and Colitis Pregnancy Knowledge Score ‘CCPKnow’) to assess knowledge of pregnancy‐related issues in IBD. The validated tool was then applied to determine knowledge in patients.Method: Discriminate ability of ‘CCPKnow’ was validated in four groups with different levels of IBD knowledge. Reliability and readability were tested by Cronbach‐α and Flesch‐Kencaid. Construct validity was subsequently assessed against general IBD knowledge (CCKnow) in 145 women with IBD. Associations between patient factors and knowledge were studied.Results: Median CCPKnow scores differed significantly between the validation groups (P < 0.001). CCPKnow displayed excellent internal consistency, reliability (Cronbach‐α 0.94), readability (reading age 9 years) and close correlation with CCKnow (Spearman's ρ 0.64; P < 0.001). Of 145 patients, 44.8% had poor, 27.6% adequate, 17.3% good and only 10.3% very good knowledge. Better knowledge was associated with Caucasian ethnicity, higher income, having a partner, having children, Crohn's and Colitis Association membership, longer disease duration and Crohn's disease.Conclusions: Crohn's and Colitis Pregnancy Knowledge Score, a novel knowledge assessment tool of pregnancy and IBD, demonstrated excellent test characteristics. We found that nearly half of the women with IBD had poor knowledge, identifying a pressing need for better education.Keywords
This publication has 19 references indexed in Scilit:
- Review article: a decision‐making algorithm for the management of pregnancy in the inflammatory bowel disease patientAlimentary Pharmacology & Therapeutics, 2012
- Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006Alimentary Pharmacology & Therapeutics, 2011
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situationsJournal of Crohn's and Colitis, 2010
- Fear and fertility in inflammatory bowel disease: A mismatch of perception and reality affects family planning decisionsInflammatory Bowel Diseases, 2009
- Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conceptionAlimentary Pharmacology & Therapeutics, 2008
- Voluntary childlessness is increased in women with inflammatory bowel diseaseInflammatory Bowel Diseases, 2007
- Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort studyAlimentary Pharmacology & Therapeutics, 2006
- American Gastroenterological Association Institute Medical Position Statement on the Use of Gastrointestinal Medications in PregnancyGastroenterology, 2006
- American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in PregnancyGastroenterology, 2006
- Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort studyGut, 2003